Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate
- PMID: 2513086
- DOI: 10.1016/0006-8993(89)91596-5
Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate
Abstract
The effects of sodium valproate on extracellularly recorded spontaneous neuronal activity and striatal-evoked inhibition in the substantia nigra zona reticulata of the rat were compared with its effects on the tissue concentration of endogenous amino acids and their spontaneous release into perfusates of this region obtained with a push-pull cannula. Valproate (200 mg/kg i.p.) produced a rapid and sustained reduction in the firing rate of all reticulata neurones tested and a concomitant increase in the duration of striatal-evoked inhibition. No change in the spontaneous release of any amino acid was observed. A significant elevation of nigral gamma-aminobutyric acid concentration was seen in both anaesthetized and non-anaesthetized animals, but this occurred only after 60 minutes. Valproate produced a rapid decline in nigral aspartate in non-anaesthetized but not in anaesthetized animals. The results of this study suggest that the acute depressant effect of valproate is unrelated to its ability to alter the concentration of GABA or aspartate in brain and is most likely due to a postsynaptic action.
Similar articles
-
Valproate effect on gamma-aminobutyric acid release in pars reticulata of substantia nigra: combination of push-pull perfusion and fluorescence histochemistry.Epilepsia. 1994 Jan-Feb;35(1):226-33. doi: 10.1111/j.1528-1157.1994.tb02938.x. Epilepsia. 1994. PMID: 8112252
-
Valproate enhances GABA turnover in the substantia nigra.Brain Res. 1989 Oct 30;501(1):198-203. doi: 10.1016/0006-8993(89)91044-5. Brain Res. 1989. PMID: 2508993
-
The effect of sodium-n-dipropyl acetate on gamma-aminobutyric acid-dependent inhibition in the rat cortex and substantia nigra in relation to its anticonvulsant activity.Br J Pharmacol. 1980;71(2):545-51. doi: 10.1111/j.1476-5381.1980.tb10971.x. Br J Pharmacol. 1980. PMID: 6781578 Free PMC article.
-
Valproate and myoclonus.Adv Neurol. 1986;43:661-74. Adv Neurol. 1986. PMID: 3080855 Review.
-
GABAergic control of substantia nigra dopaminergic neurons.Prog Brain Res. 2007;160:189-208. doi: 10.1016/S0079-6123(06)60011-3. Prog Brain Res. 2007. PMID: 17499115 Review.
Cited by
-
Epilepsy and medication effects on the pattern visual evoked potential.Doc Ophthalmol. 2005 Jan;110(1):121-31. doi: 10.1007/s10633-005-7350-0. Doc Ophthalmol. 2005. PMID: 16249963
-
The anticonvulsant response to valproate in kindled rats is correlated with its effect on neuronal firing in the substantia nigra pars reticulata: a new mechanism of pharmacoresistance.J Neurosci. 2011 Nov 9;31(45):16423-34. doi: 10.1523/JNEUROSCI.2506-11.2011. J Neurosci. 2011. PMID: 22072692 Free PMC article.
-
Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.CNS Drugs. 2002;16(10):669-94. doi: 10.2165/00023210-200216100-00003. CNS Drugs. 2002. PMID: 12269861 Review.
-
Chronic administration of valproic acid induces a decrease in rat striatal glutamate and taurine levels.Amino Acids. 1996 Jun;10(2):123-31. doi: 10.1007/BF00806585. Amino Acids. 1996. PMID: 24178474
-
Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.Neurochem Res. 1993 Apr;18(4):485-502. doi: 10.1007/BF00967253. Neurochem Res. 1993. PMID: 8097295 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources